Gene · 5920
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment. | Front Immunol | 2023 | 37153560 | PubTator, text mining | PubMed |
| PGE2 Produced by Exogenous MSCs Promotes Immunoregulation in ARDS Induced by Highly Pathogenic Influenza A through Activation of the Wnt-β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 37108459 | PubTator, text mining | PubMed |
| CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling. | Nucleic Acids Res | 2023 | 37094077 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the transcriptomic landscape of kidneys in patients with ischemic acute kidney injury. | Chin Med J (Engl) | 2023 | 37083129 | PubTator, text mining | PubMed |
| Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. | Oxid Med Cell Longev | 2023 | 37082103 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1α/NF-κB axis in psoriasis. | Cell Death Dis | 2023 | 37076497 | PubTator, text mining | PubMed |
| mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic. | Front Immunol | 2023 | 37063845 | PubTator, text mining | PubMed |
| Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction. | Front Immunol | 2023 | 37063830 | PubTator, text mining | PubMed |
| Sesamin Metabolites Suppress the Induction of Cellular Senescence. | Nutrients | 2023 | 37049468 | PubTator, text mining | PubMed |
| Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management. | Int J Mol Sci | 2023 | 37047115 | PubTator, text mining | PubMed |
| Regulation of LncRNAs and microRNAs in neuronal development and disease. | PeerJ | 2023 | 37038472 | PubTator, text mining | PubMed |
| Neurological damages in COVID-19 patients: Mechanisms and preventive interventions. | MedComm (2020) | 2023 | 37035134 | PubTator, text mining | PubMed |
| Arenaviruses: Old viruses present new solutions for cancer therapy. | Front Immunol | 2023 | 37033933 | PubTator, text mining | PubMed |
| Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors. | Eur J Med Chem Rep | 2023 | 37033416 | PubTator, text mining | PubMed |
| iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type-Specific Markers of Immune-Cell Infiltration. | Cancer Immunol Res | 2023 | 37023414 | PubTator, text mining | PubMed |
| Identification of functional pathways and potential genes associated with interferon signaling during human adenovirus type 7 infection by weighted gene coexpression network analysis. | Arch Virol | 2023 | 37017816 | PubTator, text mining | PubMed |
| The progress of molecules and strategies for the treatment of HBV infection. | Front Cell Infect Microbiol | 2023 | 37009498 | PubTator, text mining | PubMed |
| Identification of a pediatric acute hypoxemic respiratory failure signature in peripheral blood leukocytes at 24 hours post-ICU admission with machine learning. | Front Pediatr | 2023 | 37009294 | PubTator, text mining | PubMed |
| The immune checkpoint molecule, VTCN1/B7-H4, guides differentiation and suppresses proinflammatory responses and MHC class I expression in an embryonic stem cell-derived model of human trophoblast. | Front Endocrinol (Lausanne) | 2023 | 37008954 | PubTator, text mining | PubMed |
| Aberrant accumulation of NIK promotes tumor growth by dysregulating translation and post-translational modifications in breast cancer. | Cancer Cell Int | 2023 | 37005661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5920/papers?page=14